XML 53 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727
LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT WITH ASET THERAPEUTICS, LLC (Details Narrative) - Feb. 28, 2015 - USD ($)
Total
Investment amount received $ 250,000
Reimbursement revenue 75,000
Investment required by company 1,000,000
Costs and Expenses [Member]  
Reimbursement revenue 150,000
Research and Development Expense [Member]  
Reimbursement revenue 75,000
Minimum [Member]  
Other Commitment Due 5,000
Investment amount received $ 1,250,000
Equity ownership 20.00%
Maximum [Member]  
Other Commitment Due $ 25,000
Maximum [Member] | Costs and Expenses [Member]  
Reimbursement revenue $ 50,000